DORM(DORM)
DORM
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $2.21B | $2.32B | $2.46B | $2.70B |
| Low | $2.18B | $2.28B | $2.43B | $2.67B |
| High | $2.22B | $2.37B | $2.49B | $2.74B |
| EBITDA Avg | $458M | $481M | $510M | $560M |
| Low | $453M | $473M | $504M | $553M |
| High | $460M | $491M | $517M | $568M |
| EBIT Avg | $398M | $418M | $443M | $486M |
| Low | $393M | $411M | $438M | $481M |
| High | $400M | $427M | $449M | $493M |
| Net Income Avg | $267M | $277M | $305M | — |
| Low | $262M | $273M | $300M | — |
| High | $271M | $295M | $311M | — |
| EPS Avg | $8.66 | $9.29 | $9.92 | — |
| Low | $8.51 | $8.87 | $9.77 | — |
| High | $8.82 | $9.58 | $10.10 | — |
| Analysts (Rev / EPS) | 6 / 4 | 6 / 5 | 1 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $565M | $570M | $552M | $572M | $589M | $593M |
| Low | $559M | $561M | $544M | $563M | $580M | $584M |
| High | $572M | $578M | $561M | $581M | $599M | $603M |
| EBITDA Avg | $117M | $118M | $115M | $119M | $122M | $123M |
| Low | $116M | $117M | $113M | $117M | $120M | $121M |
| High | $119M | $120M | $116M | $121M | $124M | $125M |
| EBIT Avg | $102M | $103M | $99M | $103M | $106M | $107M |
| Low | $101M | $101M | $98M | $102M | $105M | $105M |
| High | $103M | $104M | $101M | $105M | $108M | $109M |
| Net Income Avg | $60M | $61M | $61M | $69M | $75M | $73M |
| Low | $59M | $55M | $60M | $67M | $74M | $72M |
| High | $61M | $66M | $62M | $70M | $77M | $75M |
| EPS Avg | $2.00 | $2.02 | $2.03 | $2.29 | $2.51 | $2.44 |
| Low | $1.98 | $1.82 | $1.99 | $2.25 | $2.46 | $2.40 |
| High | $2.05 | $2.20 | $2.08 | $2.34 | $2.56 | $2.50 |
| Analysts (Rev / EPS) | 5 / 5 | 5 / 5 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 |